Starling Oncology STLN
NASDAQ STLN
$6.51 -0.13 (-1.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

Starling Oncology (STLN) EBIT Margin (2021 - 2026)

Updated

Starling Oncology's EBIT Margin came in at -2.86% for Q2 2026, up 6.50 percentage points from -9.36% a year earlier and up 1.56 percentage points from the prior quarter.

Analysis

Starling Oncology (STLN) EBIT Margin (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Starling Oncology reported EBIT Margin of -4.44%, up 6.61 percentage points year-over-year; for FY2025, it was -7.18%, up 8.10 percentage points from FY2024.

  • EBIT Margin has increased in each of the last three years, though with a five-year change of -2.81 percentage points (FY2020 to FY2025).
  • Going back by year, EBIT Margin was -15.28% in FY2024 (+8.47 pp), -23.75% in FY2023 (+8.70 pp), -32.46% in FY2022 (-9.87 pp) and -22.59% in FY2021 (-18.22 pp).
  • The Q2 2026 figure represents the highest quarterly EBIT Margin since Q2 2021.
  • Year-over-year, EBIT Margin has increased for 13 consecutive quarters, with an average year-over-year change of +6.54 percentage points over the last eight quarters.
  • The fastest year-over-year change in EBIT Margin over five years came in Q4 2022 (a gain of 42.95 percentage points), and the weakest in Q1 2022 (a drop of 29.88 percentage points).
  • Business Quant data shows STLN's EBIT Margin at -4.42% (Q1 2026), -4.87% (Q4 2025) and -5.90% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 HCA Healthcare 94.29 Bn 93.74 Bn - 15.29%
2 Natera 59.14 Bn 54.82 Bn 485.19 Mn -10.07%
3 Quest Diagnostics 26.23 Bn 24.66 Bn 1.03 Bn 15.08%
4 Labcorp Holdings 25.04 Bn 22.81 Bn 1.11 Bn 12.10%
5 Guardant Health 23.69 Bn 19.76 Bn 219.03 Mn -38.55%
6 Tenet Healthcare 20.77 Bn 11.92 Bn - 26.67%
7 Tempus AI 14.91 Bn 11.94 Bn 246.50 Mn -19.85%
8 Encompass Health 12.24 Bn 12.70 Bn - 18.43%
9 Davita 11.39 Bn 10.15 Bn 1.16 Bn 16.29%
10 Starling Oncology 667.11 Mn 534.52 Mn 27.17 Mn -2.86%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.86%
Mar 31, 2026 -4.42%
Dec 31, 2025 -4.87%
Sep 30, 2025 -5.90%
Jun 30, 2025 -9.36%
Mar 31, 2025 -9.49%
Dec 31, 2024 -11.90%
Sep 30, 2024 -13.87%
Jun 30, 2024 -16.60%
Mar 31, 2024 -18.98%
Dec 31, 2023 -17.82%
Sep 30, 2023 -16.97%
Jun 30, 2023 -18.62%
Mar 31, 2023 -43.14%
Dec 31, 2022 -35.11%
Sep 30, 2022 -30.93%
Jun 30, 2022 -30.05%
Mar 31, 2022 -33.49%
Dec 31, 2021 -78.07%
Sep 30, 2021 -4.13%
API Access

Starling Oncology EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=STLN&period=max&api_key=YOUR_API_KEY